Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Avalo Therapeutics

    Client Virtual Booth

    AVALO THERAPEUTICS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Avalo Therapeutics
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1500 Liberty Ridge Drive Suite 321 Wayne, PA 19087
    Telephone
    Telephone
    610-254-4201
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.avalotx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/avalotx/
    Twitter
    Twitter
    https://twitter.com/Avalotx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Avalo Therapeutics Appoints Biotech Leaders to Board of Directors
    Avalo Therapeutics Appoints Biotech Leaders to Board of Directors

    https://www.globenewswire.com/news-release/2024/04/02/2855786/0/en/Avalo-Therapeutics-Appoints-Biotech-Leaders-to-Board-of-Directors.html

    GLOBENEWSWIRE
    02 Apr 2024
    Share Share
    Avalo Reports 2023 Financial Results and Provides Business Updates
    Avalo Reports 2023 Financial Results and Provides Business Updates

    https://www.globenewswire.com/news-release/2024/03/29/2854834/0/en/Avalo-Reports-2023-Financial-Results-and-Provides-Business-Updates.html

    GLOBENEWSWIRE
    29 Mar 2024
    Share Share
    Avalo snaps up AlmataBio for ex-Lilly inflammatory drug
    Avalo snaps up AlmataBio for ex-Lilly inflammatory drug

    https://www.fiercebiotech.com/biotech/avalo-signals-change-fortunes-snapping-almatabio-its-ex-lilly-inflammatory-drug

    James Waldron FIERCE BIOTECH
    28 Mar 2024
    Share Share
    Avalo Acquires Anti-IL-1 mAb and Announces Private Placement of up to $185M
    Avalo Acquires Anti-IL-1 mAb and Announces Private Placement of up to $185M

    https://www.globenewswire.com/news-release/2024/03/27/2853595/0/en/Avalo-Acquires-Anti-IL-1%CE%B2-mAb-and-Announces-Private-Placement-Financing-of-up-to-185-Million.html

    GLOBENEWSWIRE
    27 Mar 2024
    Share Share
    Avalo Therapeutics Announces 1-for-240 Reverse Stock Split
    Avalo Therapeutics Announces 1-for-240 Reverse Stock Split

    https://www.globenewswire.com//news-release/2023/12/27/2801310/0/en/Avalo-Therapeutics-Announces-1-for-240-Reverse-Stock-Split.html

    GLOBENEWSWIRE
    27 Dec 2023
    Share Share
    Avalo Encourages Stockholders to Vote FOR the Reverse Stock Split
    Avalo Encourages Stockholders to Vote FOR the Reverse Stock Split

    https://www.globenewswire.com//news-release/2023/12/07/2792379/0/en/Avalo-Encourages-Stockholders-to-Vote-FOR-the-Reverse-Stock-Split.html

    GLOBENEWSWIRE
    07 Dec 2023
    Share Share
    Avalo Reports Third Quarter 2023 Financial Results and Provides Business Updates
    Avalo Reports Third Quarter 2023 Financial Results and Provides Business Updates

    https://www.globenewswire.com//news-release/2023/11/09/2777159/0/en/Avalo-Reports-Third-Quarter-2023-Financial-Results-and-Provides-Business-Updates.html

    GLOBENEWSWIRE
    09 Nov 2023
    Share Share
    Avalo Completes Divestiture of AVTX-800 Series
    Avalo Completes Divestiture of AVTX-800 Series

    https://www.globenewswire.com//news-release/2023/10/31/2769993/0/en/Avalo-Completes-Divestiture-of-AVTX-800-Series.html

    GLOBENEWSWIRE
    31 Oct 2023
    Share Share
    Avalo Successfully Eliminates $35 Million Debt Paving the Way for Future Growth
    Avalo Successfully Eliminates $35 Million Debt Paving the Way for Future Growth

    https://www.globenewswire.com//news-release/2023/09/26/2749320/0/en/Avalo-Therapeutics-Successfully-Eliminates-35-Million-Debt-Paving-the-Way-for-Future-Growth-and-Innovation.html

    GLOBENEWSWIRE
    26 Sep 2023
    Share Share
    Avalo Enters into Agreement to Divest AVTX-800 Series
    Avalo Enters into Agreement to Divest AVTX-800 Series

    https://www.globenewswire.com//news-release/2023/09/12/2741493/0/en/Avalo-Enters-into-Agreement-to-Divest-AVTX-800-Series.html

    GLOBENEWSWIRE
    12 Sep 2023
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-05-06

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search